ReVision Optics Overview
- Founded
-
1996
- Status
-
Out of Business
- Employees
-
56
- Latest Deal Type
-
Out of Business
- Investors
-
1
ReVision Optics General Information
Description
Developer of optical technology intended to help in the treatment of presbyopia. The company's technology is used to do a patented refractive surgery to improve near vision that has been lost by the eye's natural aging process, enabling physicians to treat their patients in an enhanced way and give them better eye sight.
Contact Information
Website
www.revisionoptics.com
Formerly Known As
IntraLens Vision, Anamed
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Surgical Devices
Other Healthcare Technology Systems
Primary Office
- 25651 Atlantic Ocean Drive
- Suite A1
- Lake Forest, CA 92630
- United States
+1 (949) 000-0000
ReVision Optics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Out of Business | 30-Jan-2018 | 00000 | Completed | Out of Business | ||
| 9. Later Stage VC (Series F) | 10-Nov-2016 | 0000 | 00000 | 00000 | Completed | Generating Revenue |
| 8. Debt - General | 18-Aug-2016 | 0000 | 00000 | Completed | Generating Revenue | |
| 7. Later Stage VC (Series E) | 29-Jul-2013 | 000.00 | 00000 | 00000 | Completed | Generating Revenue |
| 6. Later Stage VC (Series E) | 16-Apr-2013 | 0000 | 000.00 | 00000 | Completed | Generating Revenue |
| 5. Later Stage VC (Series E) | 25-May-2010 | 0000 | 000.00 | 000.00 | Completed | Generating Revenue |
| 4. Later Stage VC (Series D) | 14-May-2007 | 0000 | 000.00 | 000.00 | Completed | Generating Revenue |
| 3. Later Stage VC (Series C) | 19-Oct-2005 | 0000 | 000.00 | 000.00 | Completed | Generating Revenue |
| 2. Later Stage VC (Series B) | 25-Sep-2003 | $2.77M | $5.19M | 000.00 | Completed | Generating Revenue |
| 1. Later Stage VC (Series A) | 25-Sep-2003 | $2.42M | $2.42M | Completed | Generating Revenue |
ReVision Optics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series F | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series E | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.00 |
| Series D | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series C | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
| Series B | 247,326 | $0.000100 | 8% | $11.22 | $11.22 | 1x | $11.22 | 0.29% |
| Series A | 269,500 | $0.000100 | 8% | $9.09 | $9.09 | 1x | $9.09 | 0.31% |
ReVision Optics Patents
ReVision Optics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20180325655-A1 | Corneal device inserters and methods of use | Inactive | 11-Nov-2015 | 000000000 | |
| CA-2960873-A1 | Training cornea for refractive surgery training | Inactive | 10-Sep-2014 | 000000000 | |
| EP-3191035-A1 | Training cornea for refractive surgery training | Inactive | 10-Sep-2014 | 000000000 | |
| US-20170249871-A1 | Training cornea for refractive surgery training | Inactive | 10-Sep-2014 | 000000000 | |
| AU-2015315719-A1 | Training cornea for refractive surgery training | Inactive | 10-Sep-2014 | G09B23/32 |
ReVision Optics Executive Team (11)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Joe Collins | Vice President of Operations | ||
| Nick Manesis Ph.D | Vice President, Research & Development | ||
| Louis Bunn | Chief Financial Officer |
ReVision Optics Board Members (15)
| Name | Representing | Role | Since |
|---|---|---|---|
| Frank Fischer | Self | Board Member | 000 0000 |
| Inna Eitan | ReVision Optics | Board Member | 000 0000 |
| Jay Holmes | Self | Board Member | 000 0000 |
| Stephen Slade MD | Self | Board Member | 000 0000 |
ReVision Optics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
ReVision Optics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Saints Capital | Secondary Buyer | Minority | 000 0000 | 000000 0 |